IHS FormWeb
Approved Formulary
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
IHS FormWeb
Approved Formulary
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Black Box Warnings
Please review each of these drugs carefully.
abacavir
Hypersensitivity
acetaminophen
Hepatotoxicity
acetaminophen-butalbital-caffeine
Hepatotoxicity
acetaminophen-codeine
acetaminophen: Hepatotoxicity
codeine in children: death due to ultra-rapid metabolism
acetaminophen-diphenhydrAMINE
Hepatotoxicity
acetaminophen-HYDROcodone
Hepatotoxicity
acetaminophen-oxyCODONE
acetaminophen: hepatotoxicity
oxyCODONE oral solution: risk of errors
Addition, Abuse, and Misuse; Life-Threatening Depression; Accidental Exposure; Neonatal Opioid Withdrawal Syndrome; and Hepatotoxicity
acetaminophen-traMADol
Hepatotoxicity
acetylcysteine
Inhalation solution: not for injection
adalimumab
Infection risk; malignancy in children and adolescents
aldesleukin
Capillary Leak Syndrome
alemtuzumab
Hematological toxicity; opportunistic infections
aliskiren
Pregnancy risk
alogliptin-metFORMIN
metFORMIN: Lactic Acidosis
alvimopan
Short-term hospital use only
amikacin
Neurotoxicity; nephrotoxicity
aMILoride
Hyperkalemia
amiodarone
Oral: Pneumonitis; Proarrhythmic Effects
amitriptyline
Suicidal ideation in children, adolescents
amphetamine-dextroamphetamine
Abuse/diversion potential; drug dependence
amphotericin B
Noninvasive fungal disease; avoid overdose
amphotericin B lipid complex
Lipid Emulsions: Death in preterm infants
apixaban
Discontinuation without anticoagulation
arformoterol
Asthma Related Death
ARIPiprazole
Elderly patients with dementia related psychosis
arsenic trioxide
Cardiac toxicity
asparaginase Escherichia coli
Anaphylaxis; sudden death
atenolol
Avoid abrupt withdrawal
bacitracin
Injection: Nephrotoxicity
baclofen
Intrathecal: Abrupt discontinuation
becaplermin topical
Increased risk of secondary malignancy
benazepril
ACE inhibitor pregnancy risk
benzathine penicillin-procaine penicillin
Not for Intravenous Use
bevacizumab
GI perforation; wound healing complications
bleomycin
Pulmonary Fibrosis; Idiosyncratic Reactions
budesonide-formoterol
Asthma Related Death
bumetanide
Potent diuretic
bupivacaine
Intravascular injection risk; 0.75% strength caution
bupivacaine-EPINEPHrine
Bupivacaine: Intravascular injection risk; 0.75% strength caution
bupivacaine-fentaNYL
bupivacaine: Intravascular injection risk; 0.75% strength caution
buPROPion
Suicidal Ideation
cabazitaxel
Hemtalogical & Hypersensitivity Reactions
caffeine-ergotamine
Drug interaction risk
canagliflozin
Lower Limb Amputation
candesartan
Pregnancy risk
capecitabine
Warfarin Interaction
captopril
Pregnancy risk
captopril-hydroCHLOROthiazide
captopril: Pregnancy risk
carBAMazepine
Hematological Risk; Serious Dermatologic Reactions
carbidopa-levodopa
Bolded (not boxed): Carbidopa dosing
CARBOplatin
Myelosuppression; Anaphylaxis risk
carmustine
Bone Marrow Suppression; Pulmonary Toxicity
celecoxib
Cardiovascular, gastrointestinal risk
cetuximab
Infusion Reactions; Cardiopulmonary Arrest
chloramphenicol
Fatal blood dyscrasias
chlorproMAZINE
Mortality in elderly with dementia
cidofovir
Nephrotoxicity; neutropenia
cilostazol
CHF patient contraindication
ciprofloxacin
Tendinitis; tendon rupture
CISplatin
Nephrotoxicity; Myelosuppression
citalopram
Suicidal Thoughts and Behaviors
clindamycin
Pseudomembranous colitis
cloNIDine
Epidural cloNIDine
clopidogrel
Poor CYP2C19 metabolizers
cloZAPine
Agranulocytosis, myocarditis, seizure risk
codeine
codeine in children: death due to ultra-rapid metabolism
conjugated estrogens IV
Endometrial cancer; cardiovascular; dementia risk
conjugated estrogens topical
Endometrial cancer; cardiovascular; dementia risk
cycloSPORINE
Infection, neoplasm, nephrotoxicity risk
cycloSPORINE IV
Infection, neoplasm, nephrotoxicity risk
cytarabine
Prior to initiation of therapy
dabigatran
Discontinuation without anticoagulation
dacarbazine
Hemopoietic depression; hepatic necrosis risk
DACTINomycin
Handling precautions; extravasation risk
dalfopristin-quinupristin
Approved indication
danazol
Pregnancy contraindication; stroke risk; hepatic risk with long term use; benign intracranial hypertension
dantrolene
Hepatitis risk
darbepoetin alfa
Mortality, serious CV events, tumor progression or recurrence
demo
Cardiovascular; gastrointestinal risk
denosumab
Severe Hypocalcemia in Patients with Advanced Kidney Disease
desvenlafaxine
Suicidal ideation
diatrizoate
Not for intrathecal use
diclofenac
Cardiovascular, gastrointestinal risk
didanosine
Pancreatitis, hepatotoxicity, lactic acidosis risk
dihydroergotamine
Drug interaction risk
disopyramide
Mortality Risk
DOCEtaxel
Hepatic dysfunction, hypersensitivity risk
dofetilide
Initiation or re-initiation monitoring
DOPamine
Peripheral ischemia risk
doxepin
Suicidal Ideation
DOXOrubicin
Cardiac, hepatic, myelosuppression, extravasation risk
DOXOrubicin liposomal
Cardiac, acute infusion reaction, myelosuppresssion risk
dronedarone
Contraindication in certain CHF conditions
DULoxetine
Suicidal Ideation
edetate calcium disodium
Lead encephalopathy risk
emtricitabine
Lactic Acidosis, Severe Hepatomegaly
emtricitabine-tenofovir
Emtricitabine: Lactic acidosis, severe hepatomegaly; hepB co-infection
Tenofovir: lactic acidosis, severe hepatomegaly; hepB co-infection
Lactic Acidosis; severe hepatomegaly; hep B co-infection
enalapril
Pregnancy risk
enoxaparin
Spinal/epidural hematoma risk
epiRUBicin
Myocardial toxicity; extravasation
epoetin alfa
Risk of mortality, tumor progression, cardiac events
escitalopram
Suicidal ideation
esterified estrogens
Endometrial cancer; cardiovascular; dementia risk
estradiol patch
Transdermal: endometrial cancer; cardiovascular; dementia risk
Vaginal cream/tab: endometrial cancer; cardiovascular; dementia risk
estradiol vaginal
Endometrial cancer; cardiovascular; dementia risk
Vaginal cream/tab: endometrial cancer; cardiovascular; dementia risk
ethacrynic acid
Potent Diuretic
ethinyl estradiol-norethindrone
Cigarette smoking; risk of cardiovascular disease
etodolac
Cardiovascular; gastrointestinal risk
etoposide
Myelosuppression risk
exenatide
Extended Release Injection: Risk of thyroid c-cell tumors
factor VIIa, recombinant
Serious Thrombotic Adverse Events Associated with Recombinant Coagulation Factor VIIa Outside Label Indicatons
fat emulsion, intravenous
Cautious use in infants
fentaNYL
Buccal Tablet: Serious adverse events, deaths; abuse potential
Nasal Spray: Schedule II Controlled Substance: Abuse potential
Sublingual Spray: Risk of respiratory depression, medication errors, abuse potential
Transdermal: High concentration of Schedule II opioid agonist
ferric carboxymaltose
Iron Overdose Risk
ferrous fumarate
Iron Overdose Risk
ferrous gluconate
Iron Overdose Risk
ferrous sulfate
Iron Overdose Risk
ferumoxytol
Iron Overdose Risk
flecainide
Cardiovascular risk
floxuridine
Hematological risk
flucytosine
Hepatic, hematologic risks; caution in renal impairment
fludarabine
Neurotoxicity, hemolytic anemia risk
flumazenil
Seizure Risk
FLUoxetine
Suicidal Ideation
FLUoxetine-OLANZapine
FLUoxetine: Suicidal ideation
OLANZapine:Mortality in elderly with dementia related psychosis
Sucidal Thoughts and Behaviors; Increased Mortality in Elderly Patients with Dementia-Related Psychosis
fluPHENAZine
Mortality in elderly with dementia
fluticasone-salmeterol
Salmeterol: asthma related death; pediatric and adolescent patients
fluticasone-umeclidinium-vilanterol
Asthma Related Death
fluvoxaMINE
Suicidal Ideation
fondaparinux
Spinal/epidural hematoma risk
formoterol
Asthma Related Death
foscarnet
Nephrotoxicity; seizure risk
fosinopril
Pregnancy risk
fosphenytoin
Cardiovascular risk with rapid infusion
furosemide
Potent Diuretic
ganciclovir
Hematological toxicity; IV and oral different indications
gentamicin
Ototoxicity; Nephrotoxocity
glyBURIDE-metFORMIN
Lactic Acidosis
glycopyrrolate-indacaterol
Asthma-related death
golimumab
Risk of Serious Infections, Malignancy in Children and Adolescents
haloperidol
Mortality in elderly with dementia
hemin
Use only after alternate therapy failure
heparin
Spinal/Epidural Hematomas
hydroCHLOROthiazide-losartan
Angiotensin II antagonist pregnancy risk
hydroCHLOROthiazide-methyldopa
Individualize dose
hydroCHLOROthiazide-spironolactone
Possible tumorigen
hydroCHLOROthiazide-triamterene
Hyperkalemia
hydroCHLOROthiazide-valsartan
Valsartan: ACE inhibitor pregnancy risk
HYDROmorphone
Injection: Respiratory depression risk; abuse potentia
Injection, High Potency: Opioid-tolerant patients only; Respiratory depression risk; abuse potential
Oral, extended release: Opioid-tolerant patients only; overdose risk; abuse potential
Oral, liquid & tablets: Abuse potential; respiratory depression; neonatal withdrawal; alcohol interaction
hydroxychloroquine
Prior to initiation of therapy
hydroxyurea
Prior to initiation of therapy
ibuprofen
Cardiovascular; gastrointestinal risk
ibutilide
Potentially Fatal Arrhythmias
ifosfamide
Urotoxicity; myelosuppressionm CNS toxicity
imipramine
Suicidal ideation
immune globulin intramuscular
Renal dysfunction, acute renal failure
immune globulin intravenous
Renal dysfunction, acute renal failure
immune globulin intravenous and subcutaneous
Renal dysfunction, acute renal failure
indacaterol
Asthma Related Death
indomethacin
Cardiovascular; gastrointestinal risk
inFLIXimab
Serious infection risk; hepatosplenic t-cell lymphomas; malignancy
insulin aspart
Risk of acute bronchospasm in patients with chronic lung disease
insulin aspart-insulin aspart protamine
Risk of acute bronchospasm in patients with chronic lung disease
insulin human in Normal Saline
Risk of acute bronchospasm in patients with chronic lung disease
insulin isophane (NPH)
Risk of acute bronchospasm in patients with chronic lung disease
insulin isophane-insulin regular
Risk of acute bronchospasm in patients with chronic lung disease
insulin regular
Risk of acute bronchospasm in patients with chronic lung disease
interferon alfa-2b
Neuropsychiatric, autoimmune, ischemic and infectious disorders
ipilimumab
Immune-Mediated Adverse Reactions
irbesartan
ACE inhibitor pregnancy risk
irinotecan
Severe diarrhea
iron dextran
Injection: Anaphylactic reaction risk
iron polysaccharide
Iron overdose risk
iron sucrose
Iron overdose risk
ixabepilone
Toxicity in hepatic impariment
ketamine
Emergence reactions; psychological manifestations
ketoprofen
Cardiovascular; gastrointestinal risk
ketorolac
Duration of therapy; max dose; GI, cardiovascular, bleeding, renal risk
lamiVUDine
Lactic acidosis, hepatomegaly; exacerbations of hepatitis b; dosing formulation
lamiVUDine-zidovudine
lamiVUDine: Lactic acidosis, hepatomegaly; exacerbations of hepatitis b; dosing formulation
Zidovudine: Hematological adverse events; myopathy; lactic acidosis; hepatomegaly
lamoTRIgine
Serious dermatological reactions
lapatinib
Hepatotoxicity
leflunomide
Pregnancy risk
levoFLOXacin
Tendinitis, tendon rupture
levonorgestrel
Bolded (not boxed): Not Protective Against HIV
levothyroxine
Treatment of obesity or weight loss
lidocaine topical
Lidocaine, viscous: Do NOT use for teething pain
lindane topical
Neurotoxicity
liothyronine
Treatment of obesity or weight loss
lisinopril
ACE inhibitor pregnancy risk
lithium
Monitoring recommendations
lopinavir-ritonavir
ritonavir: Drug interactions
losartan
Pregnancy risk
loxapine
Elderly patients with dementia related psychosis
Aerosol: Bronchospasm
mannitol
Severe bronchospasm risk
medroxyPROGESTERone
Cardiovascular and other risks
medroxyPROGESTERone IM
Cardiovascular and other risks
meloxicam
Cardiovascular; gastrointestinal risk
melphalan
Bone marrow suppression; hypersensitivity reactions; pregnancy risk
mercaptopurine
Bolded (not boxed): initiation of therapy
metFORMIN
Lactic Acidosis
metFORMIN-pioglitazone
metFORMIN: Lactic Acidosis
Congestive heart failure
metFORMIN-rosiglitazone
metFORMIN: Lactic Acidosis
metFORMIN-SAXagliptin
metFORMIN: Lactic Acidosis
metFORMIN-SITagliptin
metFORMIN: Lactic Acidosis
methacholine
Diagnostic use only
methadone
Risk during initiation of or conversion to methadone
methohexital
Continuous monitoring of respiratory and cardiac function
methotrexate
Bone marrow, liver, lung and kidney toxicity risk
methotrexate IV
Bone marrow, liver, lung and kidney toxicity risk
methylphenidate
Tolerance and dependence
metoclopramide
Tardive Dyskinesia
metOLazone
Bolded (not boxed): do not interchange
metroNIDAZOLE
Carcinogenicity
mexiletine
Mortality; Acute Liver Injury
midazolam
Individualize dose
midodrine
Supine blood pressure > 180 mmHg
minoxidil
Antihypertensive risk
mirtazapine
Suicidal ideation
miSOPROStol
Pregnancy risk
mitoMYcin
Bone marrow suppression; hemolytic uremic syndrome
mitoXANTRONE
Cardiotoxicity; baseline neutrophil count; extravasation risk
moexipril
ACE inhibitor pregnancy risk
morphine
24-hour observation following epidural/intrathecal administration
moxifloxacin
Tendinitis, tendon rupture
multivitamin with iron
Iron overdose risk
mycophenolate mofetil
Prior to initiation of therapy
mycophenolate mofetil IV
Prior to initiation of therapy
nabumetone
Cardiovascular; gastrointestinal risk
nadolol
Avoid abrupt withdrawal
naloxone-pentazocine
Oral use only
naltrexone
Abuse Liability
naproxen
Cardiovascular; gastrointestinal risk
nefazodone
Hepatotoxicity
neomycin
Neurotoxicity, nephrotoxicity, ototoxicity; general toxicity
nevirapine
Hepatotoxicity; dermal reactions; patient monitoring
niMODipine
Serious harm with IV administration of oral product
nitroprusside
Cyanide toxicity; hypotension risk; dilute
norEPINEPHrine
Extravasation risk
norethindrone
Cigarette smoking; risk of cardiovascular disease
nortriptyline
Suicidal ideation
OLANZapine
Mortality in elderly with dementia related psychosis
olmesartan
ACE inhibitor pregnancy risk
olodaterol
Olodaterol: Asthma-Related Death
olodaterol-tiotropium
Olodaterol: Asthma-Related Death
omalizumab
Anaphylaxis
onabotulinumtoxinA
Distant spread of toxin effect
oprelvekin
Allergic reactions, including anaphylaxis
OXALIplatin
Anaphylactic-like reactions
oxyCODONE
Oral solution: Risk of errors
Controlled release: Abuse potential
oxyMORphone
Abuse/diversion potential; drug dependence
oxytocin
Elective induction of labor
PACLitaxel
Prior to initiation of therapy
PACLitaxel protein-bound
Prior to initiation of therapy
PARoxetine
Suicidal ideation
pegloticase
Anaphylaxis and Infusion Reactions
pentostatin
Prior to initiation of therapy
perflutren
Serious cardiopulmonary reactions
perindopril
ACE inhibitor pregnancy risk
pertuzumab
Cardiomyopathy and Embryo-Fetal Toxicity
phenylephrine
Prior to initiation of therapy
phenytoin IV
Cardiovascular risk with rapid infusion
phytonadione
Severe reactions with IV use
pioglitazone
Congestive heart failure
piroxicam
Cardiovascular; gastrointestinal risk
prasugrel
Bleeding risk
primaquine
Prior to initiation of therapy
procainamide
Positive titers with chronic administration
procarbazine
Prior to initiation of therapy
prochlorperazine
Elderly patients with dementia related psychosis
progesterone
Cardiovascular disorders; breast cancer; probable dementia
promethazine
Patients < 2 years; severe tissue injury
propafenone
Mortality (CAST trial results)
propranolol
Avoid abrupt withdrawal
propylthiouracil
Severe liver injury; acute liver failure
protamine
Hypotension, pulmonary hypertension; risk factors described
prothrombin complex
Arterial and venous thromboembolic complications
QUEtiapine
Elderly patients with dementia related psychosis
quinapril
ACE inhibitor pregnancy risk
quiNINE
No benefit in leg cramps; hematologic risks
ramipril
Olmesartan: ACE inhibitor pregnancy risk
rasburicase
Anaphylaxis; hemolysis; methemoglobinemia; uric acid measure interference
risperiDONE
Elderly patients with dementia related psychosis
ritonavir
Drug interaction risk
riTUXimab
Fatal infusion reaction; mucocutaneous reactions; progressive multifocal leukoencephalopathy; hep b reactivation
rivaroxaban
Premature discontinuation; spinal/epidural hematomas
rocuronium
Prior to initiation of therapy
rosiglitazone
Thiazolidinediones, including pioglitazone and rosiglitazone, cause or exacerbate congestive heart failure in some patients.
sacubitril-valsartan
valsartan: ACE inhibitor pregnancy risk
salmeterol
Asthma Related Deaths
salsalate
Cardiovascular; gastrointestinal risk
sertraline
Suicidal ideation
sodium phosphate
Phosphate nephropathy
sotalol
Therapy initiation; renal impairment caution; product selection
spironolactone
Possible tumorigen
stavudine
Pancreatitis, lactic acidosis, hepatomegaly
streptomycin
Neurotoxicity; nephrotoxicity
streptozocin
Nephrotoxicity; experienced physician; mutagen
succinylcholine
Hyperkalemic rhabdomyolysis in infants or children
sulindac
Cardiovascular; gastrointestinal risk
SUNItinib
Hepatotoxicity has been observed in clinical trials and post-marketing experience. This hepatotoxicity may be severe and deaths have been reported.
tacrolimus
Lymphoma risk; infection related to immunosuppression
tamoxifen
Women at high risk for breast cancer; women with DCIS
telmisartan
ACE inhibitor pregnancy risk
tenofovir
Lactic acidosis, severe hepatomegaly; hepB co-infection
terbutaline
Preterm labor (injectable and oral)
testosterone
Secondary exposure to testosterone
Testosterone undecanoate, injection: POME reactions and anaphylaxis
thalidomide
Teratogen; informed consent required
thioridazine
QTc prolongation; elderly with dementia related psychosis
thiothixene
Elderly patients with dementia related psychosis
thrombin topical
Bleeding, thrombosis risk
thyroid desiccated
Treatment of obesity or weight loss
ticagrelor
Bleeding Risk
ticlopidine
Severe hematological adverse events
tigecycline
All cause mortality
timolol
Avoid abrupt withdrawal
tiZANidine
Bolded (not boxed): bioequivalence between products
tobramycin
Ototoxicity, nephrotoxicity risk with IV use
tocilizumab
Serious infections risk
tolcapone
Hepatotoxicity
topotecan
Bone marrow suppression
trastuzumab
Cardiomyopathy; infusion reactions, pulmonary toxicity; teratogenicity
traZODone
Suicidal ideation
trifluoperazine
Elderly patients with dementia related psychosis
umeclidinium-vilanterol
Asthma Related Death
valGANciclovir
Granulocytopenia, Anemia, Thrombocytopenia
valproic acid IV
Risk to children exposed in utero
valproic acid PO
Risk to children exposed in utero
valsartan
ACE inhibitor pregnancy risk
varenicline
Serious neuropsychiatric events, monitoring and patient counseling
venlafaxine
Suicidal ideation
vilazodone
Suicidal ideation
vinBLAStine
IV use only; granulocytopenia; avoid extravasation
vinCRIStine
IV use only; dose liposomal product differently
vinORELBine
IV use only; granulocytopenia; avoid extravasation
warfarin
Serious bleeding risk
zidovudine
Hematological adverse events; myopathy; lactic acidosis; hepatomegaly
ziprasidone IM
Mortality in elderly with dementia related psychosis
ziprasidone PO
Mortality in elderly with dementia related psychosis
ziv-aflibercept
Gastrointestinal hemorrhage and perforation; Compromised wound healing
zolpidem
Complex Sleep Behaviors